SCHEMBL15328232

SCHEMBL15328232

C=C(C)c1cc(N2CCOCC2)cc(F)c1C(=O)NCc1ccc(Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.46
RXFP1 Q9HBX9 1/20 0.44
LMNA P02545 2/20 0.43
MYC P01106 1/20 0.43
WDR5 P61964 1/20 0.43
NAMPT P43490 1/20 0.43
KCNH2 Q12809 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TP53 P04637 1/20 0.41
KLKB1 P03952 1/20 0.41
KLK1 P06870 1/20 0.41
EPHX2 P34913 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15328209 0.89 KMT2A (0.47) PPARGRXFP1LMNAKCNH2MEN1
SCHEMBL15328467 0.85 ERCC1 (0.47) PPARGRXFP1LMNANAMPTKMT2A
SCHEMBL15328348 0.83 LMNA (0.48) PPARGLMNAMEN1KMT2AMAPT
SCHEMBL15328281 0.83 S1PR3 (0.48) PPARGRXFP1LMNAMYCWDR5
SCHEMBL15328663 0.83 TP53 (0.48) PPARGLMNANAMPTKMT2AMAPT
SCHEMBL15328286 0.79 RXFP1 (0.48) RXFP1LMNAKCNH2MEN1KMT2A
SCHEMBL15328673 0.79 BRAF (0.45) PPARGLMNANAMPTMAPTTP53
SCHEMBL15328621 0.77 KMT2A (0.51) PPARGRXFP1LMNAKCNH2MEN1
SCHEMBL15328430 0.77 KMT2A (0.48) PPARGRXFP1LMNAMEN1KMT2A
SCHEMBL15328501 0.76 KMT2A (0.50) PPARGRXFP1LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9108936-B2 Substituted 4-aminobenzamides as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2015-08-18 US disclosed
EP-2844645-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2015-03-11 EP disclosed
WO-2013156155-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2013-10-24 WO disclosed
US-20130281452-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS GRUENENTHAL GMBH (DE) 2013-10-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130281452-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS KCNJ2, KCNQ2, KCNQ1 PPARG 1427/4885RXFP1 3878/4885LMNA 1359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.